The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.
A Watertown biotech is suspending drug development and laying off essentially all of its workers in a bid to save cash and ...
The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding, bringing its total raised to $30 million. The round was led by Bessemer ...
GlobalData on MSN
FDA and EMA release collaborative AI framework for drug development
"FDA and EMA release collaborative AI framework for drug development" was originally created and published by Pharmaceutical ...
FDA and EMA have issued 10 guiding principles for AI in drug development with the intended goal of ensuring safety and ...
AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...
Teva has penned a second pact with Royalty Pharma, this time securing up to $500 million to support the clinical development ...
Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active ...
The first day of San Francisco’s J.P. Morgan Healthcare Conference, usually punctuated by major announcements of mergers and ...
An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation ...
Zycubo received breakthrough therapy, fast track, rare paediatric disease and orphan drug designations from the FDA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback